In clinical studies, the KD was associated with better cognition but also improved brain metabolism and AD biomarkers, with lowered tau concentrations and increased Aβ42 cerebrospinal fluid levels in patients with MCI [110]. Here, MAPT is linked to Alzheimer disease.